NF2 Deficiency
2 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Gene Therapy for Neurofibromatosis Type 2 (NF2) with ST002 (NCT06834438) | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2025-02-15 |
| Oral TEAD Inhibitor Targeting the Hippo Pathway in Subjects with Advanced Solid Tumors (NCT05228015) | Ikena Oncology | 2022-01-07 |
Track NF2 Deficiency automatically
Every clearance here is in the API, with alerts when new ones post.